Anzeige
Mehr »
Login
Montag, 04.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
Sagenhafte +10.000 % Gewinnchance mit Spezialisten für KI-Cybersecurity!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3E2GR | ISIN: US4510337086 | Ticker-Symbol: 0JV0
NASDAQ
01.11.24
16:30 Uhr
2,830 US-Dollar
0,000
0,00 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
IBIO INC Chart 1 Jahr
5-Tage-Chart
IBIO INC 5-Tage-Chart

Aktuelle News zur IBIO Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
23.10.iBio, Inc. - 8-K, Current Report3
24.09.iBio, Inc. - 10-K/A, Annual Report4
20.09.iBio GAAP EPS of -$4.03, revenue of $0.23M beats by $0.2M2
20.09.iBio, Inc. - 10-K, Annual Report1
20.09.iBio, Inc.: iBio Reports Fiscal Year 2024 Financial Results and Provides Corporate Update192 SAN DIEGO, Sept. 20, 2024 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO), an AI-driven innovator of precision antibody immunotherapies, today announced its financial results for the fiscal year ended...
► Artikel lesen
20.09.iBio, Inc. - 8-K, Current Report1
03.09.iBio, Inc.: iBio to Participate in Upcoming Investor Conferences2
13.08.iBio appoints new SVP to bolster business development2
12.08.iBio, Inc.: iBio Expands Executive Leadership Team with Appointment of Kristi Sarno as Senior Vice President of Business Development2
26.07.iBio, Inc. - 8-K, Current Report4
05.07.iBio files $150M mixed shelf offering3
03.07.iBio, Inc. - 8-K, Current Report2
03.06.iBio, Inc. - 8-K, Current Report5
03.06.iBio, Inc.: iBio Closes Sale of Manufacturing Facility in Texas220- The sale of the facility eliminates $13.2M of secured debt - - Completes iBio's transition to an AI and precision biologics innovation company - SAN DIEGO, June 03, 2024 (GLOBE NEWSWIRE) -- iBio...
► Artikel lesen
13.05.iBio, Inc. - 10-Q, Quarterly Report2
13.05.iBio, Inc.: iBio Reports Fiscal Third Quarter 2024 Financial Results and Provides Corporate Update555Strengthened cash position with investment by healthcare specialist investorsExpanding into cardio-metabolic space through AstralBio collaboration BRYAN, Texas and SAN DIEGO, May 13, 2024 (GLOBE...
► Artikel lesen
13.05.iBio, Inc. - 8-K, Current Report2
27.03.Pre-market Movers: iBio, Direct Digital Holdings, Nuvation Bio, PaySign, LuxUrban Hotels465CANBERA (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 07.30 A.M. ET).In the Green iBio, Inc. (IBIO) is up over 86% at $2.14. Nuvation...
► Artikel lesen
27.03.iBio, Inc.: iBio and AstralBio Announce Transformative AI drug discovery Collaboration to Rapidly Develop Novel Antibodies for Obesity and Cardiometabolic Diseases160- Leading AI and precision biologics innovators to build a diverse set of novel best-in-class obesity treatments - - iBio to use its patented generative AI/Machine Learning platform to discover, engineer...
► Artikel lesen
26.02.iBio, Inc.: iBio Announces Sale of Preclinical PD-1 Agonist Antibody Program to Otsuka773- Deal includes $1 million upfront and potential future milestone payments - - iBio's proprietary therapeutic pipeline will now be comprised entirely of promising immuno-oncology candidates - BRYAN...
► Artikel lesen
Seite:  Weiter >>
25 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1